Quantitative relationship between myocardial concentration of tacrolimus and QT prolongation in guinea pigs: pharmacokinetic/pharmacodynamic model incorporating a site of adverse effect

scientific article

Quantitative relationship between myocardial concentration of tacrolimus and QT prolongation in guinea pigs: pharmacokinetic/pharmacodynamic model incorporating a site of adverse effect is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1001596965
P356DOI10.1023/A:1014460404352
P698PubMed publication ID11999291

P2093author name stringY Yamada
H Sato
H Ohtani
Y Sawada
T Iga
T Minematsu
P2860cites workPharmacodynamic analysis of the electrocardiographic interaction between disopyramide and erythromycin in ratsQ78019800
Identification and characterization of the murine FK506 binding protein (FKBP) 12.6 geneQ22008640
QT prolongation and Torsades de Pointes after administration of FK506Q28316162
Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectivesQ33856669
The effect of quinidine and its metabolites on the electrocardiogram and systolic time intervals: concentration--effect relationships.Q34448528
Expression of a multidrug-resistance gene in human tumors and tissuesQ34586576
Prediction of the volumes of distribution of basic drugs in humans based on data from animalsQ36611828
Blockade of the human cardiac K+ channel Kv1.5 by the antibiotic erythromycinQ36868503
Drug-induced torsade de pointes. Incidence, management and preventionQ40511780
Mechanism of block and identification of the verapamil binding domain to HERG potassium channelsQ40954779
Consensus document: therapeutic monitoring of tacrolimus (FK-506).Q40962162
QuinidineQ41670827
Immunophilins: beyond immunosuppressionQ42537553
QT prolongation and near fatal cardiac arrhythmia after intravenous tacrolimus administration: a case reportQ42539765
Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistaminesQ42541190
A comparative pharmacokinetic-pharmacodynamic study of the electrocardiographic effects of epinastine and terfenadine in ratsQ42548523
Differential effects of S6 mutations on binding of quinidine and 4-aminopyridine to rat isoform of Kv1.4: common site but different factors in determining blockers' binding affinity.Q42683777
Relationship between QaT and RR intervals in rats, guinea pigs, rabbits, and primatesQ46201403
Pharmacokinetic/pharmacodynamic analysis of tacrolimus-induced QT prolongation in guinea pigsQ46720411
P-glycoprotein-dependent disposition kinetics of tacrolimus: studies in mdr1a knockout miceQ48123911
Effects of cimetidine on quinidine distribution in ratsQ48174877
High brain densities of the immunophilin FKBP colocalized with calcineurinQ48445337
Albumin decreases myocardial permeability of unbound quinidine in perfused rat heart.Q52384117
Distribution of cardiac output in the unstressed pregnant guinea pig.Q53955950
Role of acidic phospholipids in tissue distribution of quinidine in ratsQ69228898
Pharmacokinetic-pharmacodynamic analysis of the electrocardiographic effects of terfenadine and quinidine in ratsQ71721210
Sustained QT prolongation induced by tacrolimus in guinea pigsQ73105830
Effect of the immunosupressant FK506 on excitation—contraction coupling and outward K+ currents in rat ventricular myocytesQ73500192
K(+) currents responsible for repolarization in mouse ventricle and their modulation by FK-506 and rapamycinQ73532300
Effects of hypokalaemia on arrhythmogenic risk of quinidine in ratsQ74649122
Immunophilins in the nervous systemQ77206295
Pharmacokinetic-pharmacodynamic analysis of the arrhythmogenic potency of a novel antiallergic agent, ebastine, in ratsQ77333911
Independent inhibition of calcineurin and K+ currents by the immunosuppressant FK-506 in rat ventricleQ77649641
QT interval prolongation by non-cardiovascular drugs: issues and solutions for novel drug developmentQ78004415
P433issue6
P921main subjectpharmacokineticsQ323936
pharmacodynamicsQ725307
P304page(s)533-554
P577publication date2001-12-01
P1433published inJournal of Pharmacokinetics and PharmacodynamicsQ15766045
P1476titleQuantitative relationship between myocardial concentration of tacrolimus and QT prolongation in guinea pigs: pharmacokinetic/pharmacodynamic model incorporating a site of adverse effect
P478volume28